Hypercalcaemia of malignancy and Hepatic enzyme abnormal

Summary:

Hepatic enzyme abnormal is found among people with Hypercalcaemia of malignancy, especially for people who are female, 50-59 old.

The study analyzes which people have Hepatic enzyme abnormal with Hypercalcaemia of malignancy. It is created by eHealthMe based on reports of 14 people who have Hypercalcaemia of malignancy from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Hypercalcaemia of malignancy?

Hypercalcaemia of malignancy (elevated calcium (ca+) level in the blood with cancer) is found to be associated with 88 drugs and 111 conditions by eHealthMe. Check the latest studies of Hypercalcaemia of malignancy.

What is Hepatic enzyme abnormal?

Hepatic enzyme abnormal is found to be associated with 567 drugs and 577 conditions by eHealthMe. Check the latest studies of Hepatic enzyme abnormal.



On Jul, 19, 2026

14 people who have Hypercalcaemia Of Malignancy and Hepatic Enzyme Abnormal are studied.

Would you have Hepatic enzyme abnormal when you have Hypercalcaemia of malignancy?

Gender of people who have Hypercalcaemia Of Malignancy and experienced Hepatic Enzyme Abnormal *:

  • female: 92.86 %
  • male: 7.14 %

Age of people who have Hypercalcaemia Of Malignancy and experienced Hepatic Enzyme Abnormal *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 71.43 %
  • 60+: 28.57 %

Common co-existing conditions for these people *:

  1. Multiple Myeloma (cancer of the plasma cells): 11 people, 78.57%
  2. Hypercalcaemia (elevated calcium (ca+) level in the blood): 6 people, 42.86%
  3. Breast Neoplasm (non cancerous tumour of breast): 3 people, 21.43%
  4. High Blood Pressure: 1 person, 7.14%
  5. High Blood Cholesterol: 1 person, 7.14%
  6. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 7.14%

Common drugs taken by these people *:

  1. Zometa: 11 people, 78.57%
  2. Atrovent: 11 people, 78.57%
  3. Florinef: 11 people, 78.57%
  4. Digoxin: 11 people, 78.57%
  5. Hydrocortisone: 11 people, 78.57%
  6. Kayexalate: 11 people, 78.57%
  7. Kytril: 11 people, 78.57%
  8. Lasix: 11 people, 78.57%
  9. Cytoxan: 11 people, 78.57%
  10. Cortef: 11 people, 78.57%

Common symptoms for these people *:

  1. X-Ray Abnormal: 11 people, 78.57%
  2. Enlarged Heart: 11 people, 78.57%
  3. Extremity Necrosis (death of body tissue of arms and legs): 11 people, 78.57%
  4. Facial Pain: 11 people, 78.57%
  5. Hearing Loss: 11 people, 78.57%
  6. Heart Disease: 11 people, 78.57%
  7. Hip Fracture: 11 people, 78.57%
  8. Hyperkalemia (damage to or disease of the kidney): 11 people, 78.57%
  9. Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium): 11 people, 78.57%
  10. Hypokalemia (low potassium): 11 people, 78.57%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hepatic enzyme abnormal?

- Check whether Hepatic enzyme abnormal is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Hepatic enzyme abnormal:

All the conditions that are associated with Hepatic enzyme abnormal:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hepatic enzyme abnormal and Hypercalcaemia of malignancy, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: